COVID-19: Vaccines and Therapeutics
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for Disease Control and Prevention recommends the Pfizer and Moderna vaccines for children in this age group, Assistant Secretary for Preparedness…
The AHA today published two new posters highlighting the long history of vaccines
The Food and Drug Administration Friday released an updated checklist to help clinicians screen patients for potential drug interactions before prescribing the Pfizer antiviral pill Paxlovid.
A Food and Drug Administration advisory committee yesterday recommended the agency authorize emergency use of the Novavax COVID-19 vaccine for adults.
The COVID-19 virus can be especially dangerous for women during pregnancy. This podcast talks about why pregnant women are more prone to serious infections and what they can do to protect themselves and their babies.
The COVID-19 virus can be especially dangerous for women during pregnancy.
A virtual learning program helps people get “the right care, when they need it, close to home.
Pregnant women around the country faced uncertainty upon the arrival of COVID-19.
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid.
Pfizer’s COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial.